ONO 1301Alternative Names: AP 50002; ONO 1301 - slow-release; ONO AP 50002; ONO-1301MS; SR-ONO
Latest Information Update: 15 Oct 2010
At a glance
- Originator Ono Pharmaceutical
- Class Acetic acids; Anti-inflammatories; Antiplatelets; Pyridines; Small molecules
- Mechanism of Action Prostacyclin agonists; Thromboxane synthase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Myocardial ischaemia; Pulmonary fibrosis
- Discontinued Thrombosis